Literature DB >> 1911209

Epithelial ovarian cancer: a cytokine propelled disease?

S Malik, F Balkwill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1911209      PMCID： PMC1977678          DOI： 10.1038/bjc.1991.372

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  49 in total

1.  Aetiological importance of ovulation in epithelial ovarian cancer: a population based study.

Authors:  D J Cruickshank
Journal:  BMJ       Date:  1990-09-15

2.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

Authors:  R Philip; L B Epstein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

3.  Cells secreting tumour necrosis factor show enhanced metastasis in nude mice.

Authors:  S T Malik; M S Naylor; N East; A Oliff; F R Balkwill
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

Review 4.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

Review 5.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

6.  Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes.

Authors:  G D Demetri; T J Ernst; E S Pratt; B W Zenzie; J G Rheinwald; J D Griffin
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

8.  Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha.

Authors:  D A Brenner; M O'Hara; P Angel; M Chojkier; M Karin
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

9.  Induction of synthesis of tumor necrosis factor in human and murine cell lines by exogenous recombinant human tumor necrosis factor.

Authors:  Y Niitsu; N Watanabe; H Neda; N Yamauchi; M Maeda; H Sone; H Kuriyama
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

10.  Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells.

Authors:  R M Hudziak; G D Lewis; M R Shalaby; T E Eessalu; B B Aggarwal; A Ullrich; H M Shepard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205
View more
  9 in total

1.  Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.

Authors:  Anika Agarwal; Sarah L Tressel; Rajani Kaimal; Marianthi Balla; Francis H Lam; Lidija Covic; Athan Kuliopulos
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 2.  Imaging in Tumor Immunology.

Authors:  Euishin Edmund Kim; Hyewon Youn; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2021-07-27

3.  The development of a novel immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient (SCID) mice.

Authors:  W Walker; G Gallagher
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

4.  Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.

Authors:  D P Wang; I Konishi; M Koshiyama; Y Nanbu; T Iwai; H Nonogaki; T Mori; S Fujii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.

Authors:  S T Malik; N East; D Boraschi; F R Balkwill
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

6.  Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma.

Authors:  J M Arnold; P R Huggard; M Cummings; G A Ramm; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

7.  ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function.

Authors:  Daniel R Christie; Faheem M Shaikh; John A Lucas; John A Lucas; Susan L Bellis
Journal:  J Ovarian Res       Date:  2008-10-01       Impact factor: 4.234

8.  Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene.

Authors:  G Krupitza; R Fritsche; E Dittrich; H Harant; H Huber; T Grunt; C Dittrich
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

9.  Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha.

Authors:  W K Seow; K Nakamura; Y Sugimura; Y Sugimoto; Y Yamada; D P Fairlie; Y H Thong
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.